We have rebranded from Scipex to SciQra, continuing our commitment to excellence in toxicology, product safety, and medical writing.............

We have rebranded from Scipex to SciQra, continuing our commitment to excellence in toxicology, product safety, and medical writing.............

Cube-Sides-Toxicology-Assessment-Regulatory-Compliance

SciQra LLC, located in New Jersey, is a leading consulting firm specializing in toxicology evaluation, product safety assessment, and regulatory compliance services. Our expertise extends to human health risk assessment solutions for a wide array of industries, including cosmetics, consumer products, pharmaceuticals, medical devices, and household & hygiene. Our mission is to deliver strong, scientifically grounded, and tailored solutions to address various challenges faced by our clients.

Core Competencies

Active Collaboration with Diverse Industries

Cosmetics

Personal Care

Pharmaceuticals

SciQra LLC in USA

Human health risk assessment is vital across various industries, including cosmetics, consumer products, pharmaceuticals, and medical devices. It plays a crucial role in ensuring the safety of these products and protecting consumer or patient health. Here are some key solutions and approaches used in human health risk assessment

Hazard identification: The first step in risk assessment is identifying the potential hazards associated with the ingredients or components of the products. This involves reviewing scientific literature, toxicological databases, and conducting appropriate toxicity studies to understand the potential health effects of the substances.

Toxicity assessment: Also known as a dose-response assessment, in this second step of toxicological risk assessment, various toxicity studies are reviewed for a given ingredient/substance to determine dose-dependent effects, which is critical in assessing the risk. This involves evaluating available data on the toxicological properties of the substances, including acute and chronic toxicity, skin irritation studies, eye irritation studies, skin sensitization studies (allergy), phototoxicity, photoallergy, genotoxicity, carcinogenicity, reproductive and developmental toxicity. Toxicity testing conducted in animals, in vitro toxicity testing, human clinical data, and epidemiological information are used to assess the potential adverse effects.

Exposure assessment: Assessing human exposure to the products/substance is essential for determining the level of risk. This includes evaluating the frequency and duration of product use, the amount applied or consumed, the level of substance in the product, and the potential routes of exposure (e.g., dermal, oral, inhalation). Consumer behavior and usage patterns are considered to estimate exposure levels accurately. The ultimate objective is to determine local exposure (microgram/cm2 skin surface area) and systemic exposure (mg/kg bw/day) to the ingredients or substance or product.

Risk characterization: This final step of risk assessment integrates hazard identification, dose-response, and exposure assessment to estimate the level of risk associated with product use. It involves quantifying the likelihood and severity of adverse health effects based on exposure levels and toxicological data. Risk communication plays a vital role in informing consumers about potential risks and appropriate product use.

Regulatory guidelines and standards play a crucial role in the safety evaluation of cosmetics, consumer products, pharmaceuticals, and medical devices globally. These guidelines ensure that products are developed, manufactured, and labeled in compliance with regulations, prioritizing consumer safety and well-being.

Risk assessment not only ensures regulatory compliance but also promotes the use of safer alternatives and encourages reformulation when necessary. By identifying and replacing harmful ingredients or excipients with safer alternatives or modifying formulations, potential health risks can be minimized, enhancing the overall safety of the products.

Post-market surveillance is a vital aspect of risk assessment, as it allows for the monitoring of product safety once they are in the market. By collecting data on adverse events, consumer complaints, and emerging scientific research, any potential safety concerns can be identified promptly. This enables timely actions such as product recalls, labeling changes, or the implementation of additional safety measures to protect consumers.

By regularly assessing new scientific data and advancements in technology, emerging risks can be identified and addressed proactively. This ensures that safety measures are up-to-date and aligned with the latest scientific knowledge.

Overall, human health risk assessment plays a vital role in safeguarding consumer/patient health and maintaining the integrity of the industries. It ensures thorough evaluation, regulatory compliance, and continuous improvement, leading to the development and use of safer products for consumers/patients worldwide.

Let’s connect!

 FAQs